Relieve
Natural health product licensed in Canada
- Other names
- Dermategrity Relieve, Dermategrity Relieve Cream, Relieve Cream, Scotiaderm Relieve Cream
- Licence holder
- Scotiaderm Inc.
- NPN or DIN-HM
- 80142806
- Status
- Active licence
- Licence date
- 21 July 2025
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| (11bêta)-11,17,21-trihydroxy-prégn-4-ène-3,20-dione Source : Hydrocortisone | 1 % |
Non-medicinal ingredients
Extrait de graine de Glycine Soja (Fève soja), Pétrolatum blanc, Huile minérale, Alcool cétostéarylique, Alcool benzylique, Laurate de glycérol, Eau purifiée, Cétomacrogol 1 000
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescents et adultes | minimum: 12 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Anti-itch. Anti-pruritic. For temporary relief of (external) feminine genital itching and/or (external) anal itching (due to hemorrhoids). For temporary relief of minor skin irritations (associated with redness, itching, dryness and scaling). For temporary relief of minor skin irritations, rashes, itching and redness (due to eczema, insect bites, poison ivy, poison oak, poison sumac, contact dermatitis (e.g. caused by soaps, detergents, cosmetics and/or jewellery), seborrheic dermatitis, and psoriasis).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80142806
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.